Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Protein & Cell ; (12): 267-274, 2010.
Article in English | WPRIM | ID: wpr-757729

ABSTRACT

Retinitis pigmentosa is a leading cause of blindness and a progressive retinal disorder, affecting millions of people worldwide. This disease is characterized by photoreceptor degeneration, eventually leading to complete blindness. Autosomal dominant (adRP) has been associated with mutations in at least four ubiquitously expressed genes encoding pre-mRNA splicing factors-Prp3, Prp8, Prp31 and PAP1. Biological function of adRP-associated splicing factor genes and molecular mechanisms by which mutations in these genes cause cell-type specific photoreceptor degeneration in humans remain to be elucidated. To investigate the in vivo function of these adRP-associated splicing factor genes, we examined Drosophila in which expression of fly Prp31 homolog was down-regulated. Sequence analyses show that CG6876 is the likely candidate of Drosophila melanogaster Prp31 homolog (DmPrp31). Predicted peptide sequence for CG6876 shows 57% similarity to the Homo sapiens Prp31 protein (HsPrp31). Reduction of the endogenous Prp31 by RNAi-mediated knockdown specifically in the eye leads to reduction of eye size or complete absence of eyes with remarkable features of photoreceptor degeneration and recapitulates the bimodal expressivity of human Prp31 mutations in adRP patients. Such transgenic DmPrp31RNAi flies provide a useful tool for identifying genetic modifiers or interacting genes for Prp31. Expression of the human Prp31 in these animals leads to a partial rescue of the eye phenotype. Our results indicate that the Drosophila CG6876 is the fly ortholog of mammalian Prp31 gene.


Subject(s)
Animals , Humans , Amino Acid Sequence , Animals, Genetically Modified , Base Sequence , DNA Primers , Genetics , Drosophila Proteins , Genetics , Physiology , Drosophila melanogaster , Genetics , Physiology , Eye Abnormalities , Genetics , Eye Proteins , Genetics , Physiology , Gene Knockdown Techniques , Genes, Insect , Molecular Sequence Data , Pancreatitis-Associated Proteins , Photoreceptor Cells, Invertebrate , Physiology , RNA Interference , RNA Splicing , Sequence Homology, Amino Acid
2.
Protein & Cell ; (12): 552-562, 2010.
Article in English | WPRIM | ID: wpr-757696

ABSTRACT

Progranulin (PGRN) has recently emerged as a key player in a subset of frontotemporal dementias (FTD). Numerous mutations in the progranulin gene have been identified in patients with familial or sporadic frontotemporal lobar degeneration (FTLD). In order to understand the molecular mechanisms by which PGRN deficiency leads to FTLD, we examined activity of PGRN in mouse cortical and hippocampal neurons and in human neuroblastoma SH-SY5Y cells. Treatment of mouse neurons with PGRN protein resulted in an increase in neurite outgrowth, supporting the role of PGRN as a neurotrophic factor. PGRN treatment stimulated phosphorylation of glycogen synthase kinase-3 beta (GSK-3β) in cultured neurons. Knockdown of PGRN in SH-SY5Y cells impaired retinoic acid induced differentiation and reduced the level of phosphorylated GSK-3β. PGRN knockdown cells were also more sensitized to staurosporine-induced apoptosis. These results reveal an important role of PGRN in neurite outgrowth and involvement of GSK-3β in mediating PGRN activity. Identification of GSK-3β activation as a downstream event for PGRN signaling provides a mechanistic explanation for PGRN activity in the nervous system. Our work also suggest that loss of axonal growth stimulation during neural injury repair or deficits in axonal repair may contribute to neuronal damage or axonal loss in FTLD associated with PGRN mutations. Finally, our study suggests that modulating GSK-3β or similar signaling events may provide therapeutic benefits for FTLD cases associated with PGRN mutations.


Subject(s)
Animals , Female , Humans , Mice , Pregnancy , Apoptosis , Cell Culture Techniques , Cell Differentiation , Cell Line , Embryo, Mammalian , Gene Knockdown Techniques , Glycogen Synthase Kinase 3 , Genetics , Metabolism , Glycogen Synthase Kinase 3 beta , Intercellular Signaling Peptides and Proteins , Genetics , Pharmacology , Physiology , Neurites , Physiology , Neurons , Cell Biology , Physiology , Phosphorylation , Progranulins , Proto-Oncogene Proteins c-akt , Metabolism , RNA Interference
SELECTION OF CITATIONS
SEARCH DETAIL